Blue Oak Nutraceuticals, Inc.

Blue Oak Nutraceuticals, Inc. leverages the seminal scientific discovery of Blue Oak Mitokatlyst™, the first targeted molecule clinically proven to induce mitochondrial biogenesis, to deliver a pipeline of affordable dietary supplements to more people across the globe resulting in a better quality of life.

Mitokatylst™ - E is backed by 15 preclinical and clinical studies, 45 years of combined research by the BlueOakNx scientists, and 64 peer-reviewed papers. Learn more at www.blueoaknx.com.